Frank Rimerman Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63M Sell
7,272
-40
-0.5% -$13.7K 0.15% 112
2026
Q1
$2.57M Buy
7,312
+109
+2% +$38.9K 0.17% 100
2025
Q4
$2.36M Buy
7,203
+1,411
+24% +$448K 0.15% 112
2025
Q3
$1.63M Sell
5,792
-192
-3% -$55.7K 0.1% 146
2025
Q2
$1.67M Sell
5,984
-2,286
-28% -$648K 0.11% 141
2025
Q1
$2.58M Buy
8,270
+3,656
+79% +$1.08M 0.2% 79
2024
Q4
$1.2M Sell
4,614
-9,031
-66% -$2.68M 0.09% 173
2024
Q3
$4.4M Buy
13,645
+98
+0.7% +$32.1K 0.31% 49
2024
Q2
$4.23M Buy
13,547
+13,341
+6,476% +$3.92M 0.3% 46
2024
Q1
$58.6K Hold
206
0.01% 120
2023
Q4
$59.3K Buy
+206
New +$56.1K 0.01% 118
2021
Q3
Sell
-1,597
Closed -$389K 109
2021
Q2
$389K Hold
1,597
0.15% 53
2021
Q1
$397K Hold
1,597
0.18% 49
2020
Q4
$367K Buy
+1,597
New +$368K 0.17% 57

Other funds holding AMGN

Frank Rimerman Advisors's AMGN Position: Q2 2026 in Review

Frank Rimerman Advisors reduced its Amgen (AMGN) stake by 0.55% in Q2 2026, selling an estimated $13.7K and leaving 7,272 shares worth $2.63M. The position accounts for 0.15% of the portfolio, ranked #112.

Frank Rimerman Advisors first reported a position in AMGN in Q4 2020 and has held it in 14 quarters since. The position peaked at $4.4M in Q3 2024. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Frank Rimerman Advisors held 7,272 shares of Amgen worth $2.63M as of Q2 2026.
  • Frank Rimerman Advisors sold 40 Amgen shares in Q2 2026, an estimated $13.7K.
  • Amgen made up 0.15% of Frank Rimerman Advisors's portfolio in Q2 2026, its #112 holding.
  • Frank Rimerman Advisors first reported a position in Amgen in Q4 2020 and has held it in 14 quarters since.
  • Frank Rimerman Advisors's Amgen position peaked at $4.4M in Q3 2024.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.